- Home
- OCUL vs LION Comparison
OCUL vs LION Comparison
Compare OCUL & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUL
- LION
- Stock Information
- Founded
- OCUL 2006
- LION 1997
- Country
- OCUL United States
- LION United States
- Employees
- OCUL N/A
- LION N/A
- Industry
- OCUL Biotechnology: Pharmaceutical Preparations
- LION Movies/Entertainment
- Sector
- OCUL Health Care
- LION Consumer Discretionary
- Exchange
- OCUL Nasdaq
- LION Nasdaq
- Market Cap
- OCUL 2.3B
- LION 2.0B
- IPO Year
- OCUL 2014
- LION N/A
- Fundamental
- Price
- OCUL $11.77
- LION $6.14
- Analyst Decision
- OCUL Strong Buy
- LION Buy
- Analyst Count
- OCUL 9
- LION 10
- Target Price
- OCUL $22.63
- LION $8.83
- AVG Volume (30 Days)
- OCUL 3.1M
- LION 2.1M
- Earning Date
- OCUL 11-04-2025
- LION 11-06-2025
- Dividend Yield
- OCUL N/A
- LION N/A
- EPS Growth
- OCUL N/A
- LION N/A
- EPS
- OCUL N/A
- LION N/A
- Revenue
- OCUL $56,664,000.00
- LION $3,986,900,000.00
- Revenue This Year
- OCUL N/A
- LION N/A
- Revenue Next Year
- OCUL $17.75
- LION $21.07
- P/E Ratio
- OCUL N/A
- LION N/A
- Revenue Growth
- OCUL N/A
- LION 10.89
- 52 Week Low
- OCUL $5.79
- LION $5.55
- 52 Week High
- OCUL $13.85
- LION $8.50
- Technical
- Relative Strength Index (RSI)
- OCUL 50.07
- LION 43.07
- Support Level
- OCUL $11.31
- LION $6.31
- Resistance Level
- OCUL $11.78
- LION $6.59
- Average True Range (ATR)
- OCUL 0.47
- LION 0.26
- MACD
- OCUL 0.01
- LION 0.02
- Stochastic Oscillator
- OCUL 54.47
- LION 37.06
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About LION Lionsgate Studios Corp. Common Shares
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.